AKBA: Akebia Therapeutics, Inc. Stock

by  •  • Comments Off on AKBA: Akebia Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,371.75
Enterprise Value ($M) 1,494.43
Book Value ($M) -49.19
Book Value / Share -0.19
Price / Book -27.78
NCAV ($M) -156.02
NCAV / Share -0.60
Price / NCAV -8.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.20
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.21
Current Ratio 1.41

Balance Sheet (mrq) ($M)
Current Assets 113.83
Assets 220.67
Liabilities 269.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 160.18
Operating Income -46.21
Net Income -69.41
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -40.66
Cash from Investing -0.03
Cash from Financing 49.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G Vanguard Group Inc 5.37 66.75
04-17 13G/A BlackRock, Inc. 6.10 -0.36
02-14 13G/A Satter Muneer A 2.60 -64.53

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 2,460,986 9,469,485 25.99
2025-05-07 1,104,856 3,539,409 31.22
2025-05-06 1,346,041 3,582,255 37.58
2025-05-05 1,023,897 2,919,894 35.07

(click for more detail)

Similar Companies
AGEN – Agenus Inc. AIMD – Ainos, Inc.
AKAN – Akanda Corp. ALDX – Aldeyra Therapeutics, Inc.
ALGS – Aligos Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io